The Benefits Participation & Premium Cost Analytics Dashboard joins Businessolver's growing suite of Benefits Insights Dashboards, which includes analytics designed to surface engagement trends, ...

The numbers reflect this pain, with 40% of organizations either replacing or re-implementing their IT service tools in 2025.

Using AI to assemble real-world COPD data can help to identify specific clinical traits faster and with greater accuracy than traditional data sources This collaboration supports Tessel's drug ...

Dolby and LG launch the LG Sound Suite featuring the world’s first Dolby Atmos FlexConnect soundbar for customizable ...

This umbrella review synthesised five meta-analyses to estimate the reported prevalence of orthorexia nervosa and examine its ...

Jesta I.S. today announced the launch of FarsightIQ, a new AI-focused division delivering what the company calls one of retail's most advanced AI-driven commerce platforms?where machine learning and ...

UNIONDALE, NY / ACCESS Newswire / December 18, 2025 / Marquis Who's Who has recognized Adam Smith for expertise at the crossroads of insurance and technology, spotlighting a career built on designing ...

About GLPG3667, the GALARISSO (NCT: 05695950) and GALACELA (NCT: 05856448) studies GLPG3667 is an investigational reversible and selective tyrosine kinase 2 (TYK2) kinase domain inhibitor currently ...

Now, with the European Union Health Technology Assessment (HTA) regulation coming into force as part of the required Joint Clinical Assessment (JCA) for oncology and advanced therapy medicinal ...

The map of global carmaking is being quietly redrawn. Not with press releases or ribbon cuttings, but with factory schedules, ...

For end users, Cerence xUI delivers a seamless, intuitive, and engaging experience. The platform’s multi-step conversational threads, multi-modal capabilities, and enhanced personalization transform ...

GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of disease activity compared to pla ...